Arya Biragyn
Department of Experimental Transplantation and Immunology
NCI, Frederick
MD 21702-1201
USA
Name/email consistency: high
- DNA vaccines encoding human immunodeficiency virus-1 glycoprotein 120 fusions with proinflammatory chemoattractants induce systemic and mucosal immune responses. Biragyn, A., Belyakov, I.M., Chow, Y.H., Dimitrov, D.S., Berzofsky, J.A., Kwak, L.W. Blood (2002)
- Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Biragyn, A., Ruffini, P.A., Leifer, C.A., Klyushnenkova, E., Shakhov, A., Chertov, O., Shirakawa, A.K., Farber, J.M., Segal, D.M., Oppenheim, J.J., Kwak, L.W. Science (2002)
- Mediators of innate immunity that target immature, but not mature, dendritic cells induce antitumor immunity when genetically fused with nonimmunogenic tumor antigens. Biragyn, A., Surenhu, M., Yang, D., Ruffini, P.A., Haines, B.A., Klyushnenkova, E., Oppenheim, J.J., Kwak, L.W. J. Immunol. (2001)
- B-cell malignancies as a model for cancer vaccines: from prototype protein to next generation genetic chemokine fusions. Biragyn, A., Kwak, L.W. Immunol. Rev. (1999)